Alere Asks What Abbott Knew Prior to Merger Agreement

Alere called on a Delaware judge to adopt the recommendations of a court mediator and direct Abbott Labs to share premerger attorney notes and other materials about its acquisition of the Waltham, Mass., medical device maker, asserting the notes are critical to determining exactly what Abbott knew when it agreed to the deal.featured

Ruling Boxes Alere’s Arriva Unit Into Corner

Attorneys for Arriva Medical agreed in court this morning they have few options to revive the Alere subsidiary’s chances of getting its Medicare payment privileges restored before Alere faces off next month with Abbott Labs over the two companies’ disputed merger.featured

Court Order Could Tip Delaware Case in Abbott’s Favor

Last Friday’s ruling by a federal court in Washington, D.C., against Alere’s Arriva Medical subsidiary could help persuade the Delaware Chancery Court to allow Abbott Laboratoriesfeatured

Judge Orders Abbott and Alere to Cooperate

A Delaware judge directed Abbott Laboratories and Alere to settle their differences over exchanging information on Abbott’s attempts to break its $5.8 billion acquisition of Alere, the Massachusetts maker of medical diagnostic kits.featured

Judge to Rule by End of Month on Alere’s Arriva Medical Unit

A federal judge said this afternoon that he will decide by the end of the month whether to restore Arriva Medical’s Medicare billing rights while an administrative law judge determinesfeatured

Alere Races Against Trial Date to Complete Arriva Medical Appeal

Alere is hoping to erase one major obstacle to its merger with Abbott Laboratories — the uncertainty over its Arriva Medical subsidiary — before an April court date that will determine thefeatured

Corrected: Judge Promises to Protect Alere from Impending Drop-Dead Date

Revised at 1:56pm EST – The Delaware Chancery Court has set aside six days at the end of April for a trial to determine whether Abbott Laboratories can walk away from its acquisition of Alere, which would brush upfeatured

Judge Plans April Trial Over Alere/Abbott Break-Up

A Delaware judge rejected pleas by Alere Inc. to schedule a fast trial over the company’s efforts to salvage its $5.8 billion acquisition by Abbott Laboratories, siding instead with Abbott’s request for an April court date. Alere had asked the court for an expedited trial beginningfeatured

Abbott Builds Case Against Alere Merger

Alere Inc., which is fighting to save its merger with Abbott Laboratories, agreed Tuesday to share more information about the variety of investigations into its practices being conducted by federal agencies. The agreement comes as Abbott continues to unveil information about the investigations through a suit filed November 4, askingfeatured

Abbott Says Suit Not Aimed at Breaking Alere Deal

Abbott Laboratories said a new suit seeking confidential legal and regulatory information from Alere is not an attempt to break the companies’ $5.4 billion merger, even as the companies accelerate toward a January court date that could do just that. “The objective of the (new) lawsuit is to obtain important information before the transaction is … Read Morefeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.